U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07596654) titled 'The Impact of Surgical Treatment on Survival in Localized Small Cell Esophageal Cancer' on May 09.
Brief Summary: Limited-stage small cell esophageal carcinoma (LS-SCEC) is a rare and highly aggressive malignancy with poor prognosis and no established standard treatment strategy. Due to its low incidence, current evidence is mainly derived from small retrospective studies, and the role of surgery in multimodal treatment remains controversial. In particular, the survival benefit of surgical treatment compared with definitive non-surgical therapy has not been fully clarified.
This single-center retrospective cohort study aims to evalu...